Most Biliary Tract Cancer Patients in China Miss Guideline-Recommended Immunotherapy, Survey Finds
A nationwide survey of 120 Chinese physicians reveals that most patients with advanced biliary tract cancer never receive guideline-recommended immunotherapy ...
